- G7 urges Taliban to lift ban on female aid workers as UN suspends ‘time-sensitive’ program in Afghanistan - July 8, 2022
- Archaeologists find hints of oldest known weapon used in America - July 8, 2022
- Moscow police chief informs about lifting emergency call in murder of university student - March 17, 2022
A parliamentary committee in The Gambia has urged the government to take legal action against an Indian pharmaceutical company accused of causing the deaths of at least 70 children in the West African country. recommended.
Maiden Pharmaceuticals should be banned and authorities should take strict action against companies using contaminated raw materials to make cough syrup, says Gambian parliamentary health committee said in a report on Tuesday.
The report comes after weeks of investigation by the commission, saying scientific research into the actual causes of children’s deaths is still ongoing.
The World Health Organization (WHO) has issued a global alert over her four cough syrups linked to her 70 child deaths in The Gambia and advised regulators to stop selling the drug. .
Last week, the Indian government told the WHO that its cough syrup was “prematurely” linked to a child’s death in The Gambia, “has a negative impact on the image of the country’s pharmaceutical industry”.
